Orinove Inc.,

Company Overview

Orinove Inc., is a pharmaceutical company focused on novel products for the treatment of unmet medical needs and serious diseases. Our lead product candidate is a proprietary oral compound, ORIN1001, for the treatment of cancer. ORIN1001 is currently in Phase I clinical trials for the treatment of advanced solid tumors and relapsed refractory metastatic breast cancer. https://www.clinicaltrials.gov/ORIN1001 is under evaluation for clinical development in Idiopathic Pulmonary Fibrosis (IPF).